<DOC>
	<DOC>NCT02051673</DOC>
	<brief_summary>Four subjects were treated under compassionate use provisions under this study with facilitating cell therapy (FCRx)</brief_summary>
	<brief_title>Induction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Patient must be between the ages of 18 and 65 years and meet the institution's criteria for renal transplantation for endorgan failure Patient is receiving first renal transplant Patient is receiving a renal transplant only The crossmatch is negative between donor and recipient Women who are of child bearing potential must have a negative pregnancy test (urine test is acceptable) within 48 hours of initiating total body irradiation (TBI) and agree to use reliable contraception for 1 year following transplant Potential donors who are women of child bearing potential must have a negative pregnancy test (urine test is acceptable) within 48 hours prior to receiving Granulocyte colonystimulating factor (GCSF) No evidence of donorspecific antibody presently or historically Clinically active bacterial, fungal, viral or parasitic infection Pregnancy Clinical or serologic evidence of viral infection which would preclude the recipient from receiving a kidney transplant Previous radiation therapy at a dose which would preclude TBI Positive crossmatch between donor and recipient Evidence for immunologic memory against donor BMI &gt;35 or &lt;18 Retransplant Positive serologies for hepatitis B virus (HBV), hepatitis C virus (HCV), HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Kidney Transplantation</keyword>
</DOC>